Cargando…
Integrated proteomics and metabolomics analysis of lumbar in a rat model of osteoporosis treated with Gushukang capsules
BACKGROUND: Gushukang (GSK) capsules are a Chinese patented medicine that is widely used in clinics for the treatment of osteoporosis (OP). Animal experiments have revealed that the bone mineral density of osteoporotic rats increase after treatment with GSK capsules. However, the specific mechanism...
Autores principales: | Lin, Ruohui, Xie, Bingying, Xie, Lihua, Ge, Jirong, Li, Shengqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756464/ https://www.ncbi.nlm.nih.gov/pubmed/36522793 http://dx.doi.org/10.1186/s12906-022-03807-7 |
Ejemplares similares
-
Chinese medicine Gushukang capsule for treating primary osteoporosis: a systematic review and meta-analysis
por: Liu, Tianpeng, et al.
Publicado: (2023) -
Effects of Gushukang for postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
por: Wang, Guangwei, et al.
Publicado: (2020) -
Positive Effect of Gushukang on Type-H Vessel and Bone Formation
por: Li, Wantao, et al.
Publicado: (2020) -
Comparisons of gene expression between peripheral blood mononuclear cells and bone tissue in osteoporosis
por: Xie, Lihua, et al.
Publicado: (2023) -
Association of cardiotrophin-like cytokine factor 1 levels in peripheral blood mononuclear cells with bone mineral density and osteoporosis in postmenopausal women
por: Chen, Xuan, et al.
Publicado: (2021)